Evidence map›Paper›PMID 39450292›Full record

ArticleCurrent opinion in biomedical engineering2020

Growth and remodeling of atrioventricular heart valves: A potential target for pharmacological treatment?

Manuel K Rausch

Abstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Leaflet remodeling reduces tricuspid valve function in a computational model.Journal of the mechanical behavior of biomedical materials · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Tricuspid Valve Annuloplasty Alters Leaflet Mechanics.Annals of biomedical engineering · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Manuel K RauschDepartments of Aerospace Engineering & Engineering Mechanics, Biomedical Engineering, Oden Institute for Computational Engineering and Sciences, University of Texas at Austin, Austin, TX, USA.

Funding

American Heart Association-American Stroke Association 18CDA34120028
6 · The paper itself

Abstract

The atrioventricular heart valves, i.e., the mitral valve and the tricuspid valve, play vital roles in our cardiovascular system. Disease of these valves is therefore a significant source of morbidity and mortality. Unfortunately, current treatment options are suboptimal with significant rates of failure. It was only recently that we have begun to appreciate that the atrioventricular heart valve leaflets are not just passive flaps, but actively (mal-)adapting tissues. This discovery sheds new light on disease mechanisms and provides, thus, possible pathways to new treatments. In this current opinion piece, we examine the state of our knowledge about the (mal-)adaptive mechanisms (physiological and pathological growth and remodeling) of the atrioventricular heart valves. Furthermore, we review the evidence that suggests that valve maladaptation may be a target for pharmacological treatment of diseased valves which, in the future, could transform clinical practice.

Indexed as

AdaptationDiseaseHealthInsufficiencyMaladaptationMitral ValveRegurgitationTricuspid Valve

Identifiers

PMID39450292
PMCPMC11500836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.